PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Brain Ischemia D002545 89 associated lipids
Seizures D012640 87 associated lipids
Arteriosclerosis D001161 86 associated lipids
Atherosclerosis D050197 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Alzheimer Disease D000544 76 associated lipids
Stomach Ulcer D013276 75 associated lipids
Leukemia D007938 74 associated lipids
Hyperlipidemias D006949 73 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Coronary Disease D003327 70 associated lipids
Melanoma D008545 69 associated lipids
Colitis D003092 69 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Neuroblastoma D009447 66 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Reperfusion Injury D015427 65 associated lipids
Pain D010146 64 associated lipids
Weight Loss D015431 56 associated lipids
Nerve Degeneration D009410 53 associated lipids
Parkinson Disease D010300 53 associated lipids
Asthma D001249 52 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Osteosarcoma D012516 50 associated lipids
Thrombosis D013927 49 associated lipids
Precancerous Conditions D011230 48 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Leukemia P388 D007941 43 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypotension D007022 41 associated lipids
Arthritis D001168 41 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Peritonitis D010538 38 associated lipids
Lung Diseases D008171 37 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Cataract D002386 34 associated lipids
Acute Lung Injury D055371 33 associated lipids
Uremia D014511 33 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Stroke D020521 32 associated lipids
Catalepsy D002375 30 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Drug Eruptions D003875 30 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Endotoxemia D019446 27 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Nasal Polyps D009298 26 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Hyperemia D006940 25 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Fibrosis D005355 23 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Erythema D004890 22 associated lipids
Hypersensitivity D006967 22 associated lipids
Sarcoma 180 D012510 21 associated lipids
Myocardial Infarction D009203 21 associated lipids
Helicobacter Infections D016481 21 associated lipids
Translocation, Genetic D014178 20 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Pleurisy D010998 20 associated lipids
Parkinsonian Disorders D020734 20 associated lipids
Peptic Ulcer D010437 19 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Cough D003371 19 associated lipids
Hypothermia D007035 19 associated lipids
Down Syndrome D004314 18 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Bronchial Spasm D001986 18 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Ramji DP Growth hormone-releasing peptides, CD36, and stimulation of cholesterol efflux: cyclooxygenase-2 is the link. 2009 Cardiovasc. Res. pmid:19520704
Kanaoka Y et al. Cloning and crystal structure of hematopoietic prostaglandin D synthase. 1997 Cell pmid:9323136
Nagy L et al. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. 1998 Cell pmid:9568715
Forman BM et al. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. 1995 Cell pmid:8521497
Kliewer SA et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. 1995 Cell pmid:8521498
Tontonoz P et al. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. 1998 Cell pmid:9568716
Takai T et al. FcR gamma chain deletion results in pleiotrophic effector cell defects. 1994 Cell pmid:8313472
Rehan V and Torday J Hyperoxia augments pulmonary lipofibroblast-to-myofibroblast transdifferentiation. 2003 Cell Biochem. Biophys. pmid:12794266
Makino N et al. Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia. 2006 Cell Biochem. Biophys. pmid:16456235
Maggiora M et al. Involvement of PPARα and PPARγ in apoptosis and proliferation of human hepatocarcinoma HepG2 cells. 2010 Cell Biochem. Funct. pmid:20862655
Torii SI et al. Thiazolidinedione induces the adipose differentiation of fibroblast-like cells resident within bovine skeletal muscle. 1998 Cell Biol. Int. pmid:10328850
Wang JJ and Mak OT Induction of apoptosis in non-small cell lung carcinoma A549 cells by PGDâ‚‚ metabolite, 15d-PGJâ‚‚. 2011 Cell Biol. Int. pmid:21999315
Akrishnan VR and Menon VP Potential role of antioxidants during ethanol-induced changes in the fatty acid composition and arachidonic acid metabolites in male Wistar rats. 2001 Cell Biol. Toxicol. pmid:11504446
Zhu F et al. Prostaglandin (PG)D(2) and 15-deoxy-Delta(12,14)-PGJ(2), but not PGE(2), mediate shear-induced chondrocyte apoptosis via protein kinase A-dependent regulation of polo-like kinases. 2010 Cell Death Differ. pmid:20150912
Lalier L et al. Prostaglandins antagonistically control Bax activation during apoptosis. 2011 Cell Death Differ. pmid:20966963
Figarella K et al. Prostaglandin D2 induces programmed cell death in Trypanosoma brucei bloodstream form. 2005 Cell Death Differ. pmid:15678148
Figarella K et al. Prostaglandin-induced programmed cell death in Trypanosoma brucei involves oxidative stress. 2006 Cell Death Differ. pmid:16456581
Austin S et al. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells. 1998 Cell Growth Differ. pmid:9543393
Butler R et al. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2. 2000 Cell Growth Differ. pmid:10672903
Campo PA et al. Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2). 2002 Cell Growth Differ. pmid:12354750
Hennersdorf F et al. Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation. 2005 Cell Res. pmid:15916720
Merwald H et al. Induction of the 72-kilodalton heat shock protein and protection from ultraviolet B-induced cell death in human keratinocytes by repetitive exposure to heat shock or 15-deoxy-delta(12,14)-prostaglandin J2. 2006 Cell Stress Chaperones pmid:16572732
Hamel L et al. Induction of heat shock protein 70 by herbimycin A and cyclopentenone prostaglandins in smooth muscle cells. 2000 Cell Stress Chaperones pmid:11147963
Gualde N et al. Stimulation of prostaglandin synthesis by the serum factor (FTS). 1982 Cell. Immunol. pmid:6957270
Mulkins MA et al. Mycophenolic acid inhibits the degranulation of rat peritoneal mast cells. 1992 Cell. Immunol. pmid:1349511
Burke SJ and Collier JJ The gene encoding cyclooxygenase-2 is regulated by IL-1β and prostaglandins in 832/13 rat insulinoma cells. 2011 Cell. Immunol. pmid:21885043
Bancos S et al. Induction of heme oxygenase-1 in normal and malignant B lymphocytes by 15-deoxy-Delta(12,14)-prostaglandin J(2) requires Nrf2. 2010 Cell. Immunol. pmid:20064636
Parker CW et al. Modulation of IL-4 production in murine spleen cells by prostaglandins. 1995 Cell. Immunol. pmid:7720090
Moon TC et al. Regulation of cyclooxygenase-2 and endogenous cytokine expression by bacterial lipopolysaccharide that acts in synergy with c-kit ligand and Fc epsilon receptor I crosslinking in cultured mast cells. 1998 Cell. Immunol. pmid:9636692
Farnesi-de-Assunção TS et al. PPAR-γ agonists, mainly 15d-PGJ(2), reduce eosinophil recruitment following allergen challenge. 2012 Cell. Immunol. pmid:22192475
Lahaye DH et al. Effect of bradykinin on loss of density-dependent growth inhibition of normal rat kidney cells. 1994 Cell. Mol. Biol. (Noisy-le-grand) pmid:7981625
Muñoz U et al. On the mechanism of inhibition of p27 degradation by 15-deoxy-Delta12,14-prostaglandin J2 in lymphoblasts of Alzheimer's disease patients. 2008 Cell. Mol. Life Sci. pmid:18818877
Olmos G et al. 15-Deoxy-Delta(12,14)-prostaglandin-J(2) reveals a new pVHL-independent, lysosomal-dependent mechanism of HIF-1alpha degradation. 2009 Cell. Mol. Life Sci. pmid:19458911
Xu X et al. Effect of Salusin-β on Peroxisome Proliferator-Activated Receptor Gamma Gene Expression in Vascular Smooth Muscle Cells and its Possible Mechanism. 2015 Cell. Physiol. Biochem. pmid:26279448
Meng Y et al. Angiotensin II-induced Egr-1 expression is suppressed by peroxisome proliferator-activated receptor-γ ligand 15d-PGJ₂ in macrophages. 2015 Cell. Physiol. Biochem. pmid:25591955
Niemoeller OM et al. Ciglitazone and 15d-PGJ2 induced suicidal erythrocyte death. 2008 Cell. Physiol. Biochem. pmid:18769050
Ye F et al. Quantitative characterization of 15-deoxy-delta(12,14)-prostaglandin J2 in regulating EGFPSmad2 translocation in CHO cells through PPARgamma/TGFbeta/Smad2 pathway. 2006 Cell. Physiol. Biochem. pmid:16914899
Dieter P et al. Lipopolysaccharide-induced release of arachidonic acid and prostaglandins in liver macrophages: regulation by Group IV cytosolic phospholipase A2, but not by Group V and Group IIA secretory phospholipase A2. 2002 Cell. Signal. pmid:11812647
Yucel-Lindberg T et al. Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts. 2006 Cell. Signal. pmid:16766159
Nosjean O and Boutin JA Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part? 2002 Cell. Signal. pmid:11955950
Olmos G et al. Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism. 2007 Cell. Signal. pmid:17658243
Patel KM et al. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma). 2005 Cell. Signal. pmid:15993751
Mo C et al. PPARgamma regulates LIF-induced growth and self-renewal of mouse ES cells through Tyk2-Stat3 pathway. 2010 Cell. Signal. pmid:19922793
Kozawa O et al. Mechanism of prostaglandin D(2)-stimulated heat shock protein 27 induction in osteoblasts. 2001 Cell. Signal. pmid:11483406
Imamura Y et al. Mechanism of phospholipase D activation induced by prostaglandin D2 in osteoblast-like cells: function of Ca2+/calmodulin. 1995 Cell. Signal. pmid:7756110
Wienecke T et al. Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin Dâ‚‚ (PGDâ‚‚). 2011 Cephalalgia pmid:20974593
Takahashi N et al. Molecular characterization of TRPA1 channel activation by cysteine-reactive inflammatory mediators. 2008 Jul-Aug Channels (Austin) pmid:18769139
Tanaka H et al. Polymer-assisted solution-phase synthesis and neurite-outgrowth-promoting activity of 15-deoxy-delta(12,14)-PGJ2 derivatives. 2006 Chem Asian J pmid:17441107
Genovese A et al. Human cardiac mast cells in anaphylaxis. 2010 Chem Immunol Allergy pmid:20519884
Boyce JA Eicosanoid mediators of mast cells: receptors, regulation of synthesis, and pathobiologic implications. 2005 Chem Immunol Allergy pmid:16107763
Chen S et al. 15-Deoxy-Δ(12,14)-prostaglandin J2 (15d-PGJ2) promotes apoptosis of HBx-positive liver cells. 2014 Chem. Biol. Interact. pmid:24582817
Byrns MC and Penning TM Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs. 2009 Chem. Biol. Interact. pmid:19010312
Charlesworth EN Role of basophils and mast cells in acute and late reactions in the skin. 1995 Chem. Immunol. pmid:7546286
Quan GH et al. Anti-allergic flavones from Arthraxon hispidus. 2013 Chem. Pharm. Bull. pmid:23995356
Kang SS et al. Cyclooxygenase-2 inhibitory cerebrosides from phytolaccae radix. 2001 Chem. Pharm. Bull. pmid:11253924
Reilly TP et al. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. 2001 Chem. Res. Toxicol. pmid:11743745
Bogaards JJ et al. Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1. 1997 Chem. Res. Toxicol. pmid:9084911
Ravindra KC et al. Targeting of histone acetyltransferase p300 by cyclopentenone prostaglandin Δ(12)-PGJ(2) through covalent binding to Cys(1438). 2012 Chem. Res. Toxicol. pmid:22141352
Song NY et al. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells. 2011 Chem. Res. Toxicol. pmid:21728338
Ishii T and Uchida K Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2. 2004 Chem. Res. Toxicol. pmid:15487891
Uchida K and Shibata T 15-Deoxy-Delta(12,14)-prostaglandin J2: an electrophilic trigger of cellular responses. 2008 Chem. Res. Toxicol. pmid:18052108
Brunoldi EM et al. Cyclopentenone prostaglandin, 15-deoxy-Delta12,14-PGJ2, is metabolized by HepG2 cells via conjugation with glutathione. 2007 Chem. Res. Toxicol. pmid:17854155
Busse WW et al. Biomarker Profiles in Asthma With High vs Low Airway Reversibility and Poor Disease Control. 2015 Chest pmid:26226215
Zehr BB et al. Use of segmental airway lavage to obtain relevant mediators from the lungs of asthmatic and control subjects. 1989 Chest pmid:2539958
Christman BW Lipid mediator dysregulation in primary pulmonary hypertension. 1998 Chest pmid:9741570
Robbins IM et al. Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension. 2001 Chest pmid:11713147
Han S et al. Ligands of peroxisome proliferator-activated receptor gamma inhibit lung cancer cell growth and induce apoptosis by stimulation of P21 expression. 2004 Chest pmid:15136464
Keum JH et al. The anti-inflammatory effect of Cheongseoikki-tang ethanol extract on allergic reactions mediated by bone marrow-derived mast cells. 2013 Chin J Integr Med pmid:23494327
Wang Y et al. Role of cyclooxygenase-2 signaling pathway dysfunction in unexplained recurrent spontaneous abortion. 2010 Chin. Med. J. pmid:20819509
Chen WC et al. Induction of apoptosis in colorectal cancer cells by peroxisome proliferators-activated receptor gamma activation up-regulating PTEN and inhibiting PI3K activity. 2005 Chin. Med. J. pmid:16157051
Yuan ZY et al. PPAR-gamma ligands inhibit the expression of inflammatory cytokines and attenuate autoimmune myocarditis. 2004 Chin. Med. J. pmid:15361304
Ye P et al. Activation of peroxisome proliferator-activated receptor alpha in human endothelial cells increases plasminogen activator inhibitor type-1 expression. 2003 Chin. Med. J. pmid:12667383
Tang Q et al. Effect of 15-Deoxy-Δ12,14-prostaglandin J2Nanocapsules on Inflammation and Bone Regeneration in a Rat Bone Defect Model. 2017 Chin. Med. J. pmid:28139520
Matsumoto T et al. Lipocalin-type prostaglandin D synthase is associated with coronary vasospasm and vasomotor reactivity in response to acetylcholine. 2011 Circ. J. pmid:21325722
Osanai T and Okumura K Lipocalin-type PGD synthase as a novel biomarker for coronary vasospasm. 2011 Circ. J. pmid:21378446
Nagoshi H et al. Prostaglandin D2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. 1998 Circ. Res. pmid:9468191
Taba Y et al. Fluid shear stress induces lipocalin-type prostaglandin D(2) synthase expression in vascular endothelial cells. 2000 Circ. Res. pmid:10807869
Soler M et al. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. 2000 Circ. Res. pmid:10988243
Kwak BR et al. PPARgamma but not PPARalpha ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells. 2002 Circ. Res. pmid:11861426
Charles RL et al. Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilation. 2011 Circ. Res. pmid:21164107
Braun M and Schrör K Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation. 1992 Circ. Res. pmid:1385004
Marx N PPARgamma and vascular inflammation: adding another piece to the puzzle. 2002 Circ. Res. pmid:12215484
Takata Y et al. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma. 2002 Circ. Res. pmid:12215492
Marx N et al. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. 1998 Circ. Res. pmid:9831704
Yano M et al. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. 2007 Circ. Res. pmid:17463321
Di Francesco L et al. Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells. 2009 Circ. Res. pmid:19122175
King LS et al. Pulmonary vascular effects of prostaglandin D2, but not its systemic vascular or airway effects, are mediated through thromboxane receptor activation. 1991 Circ. Res. pmid:1825033
Verrier E et al. PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase. 2004 Circ. Res. pmid:15117825
Tobiasova Z et al. Peroxisome proliferator-activated receptor-γ agonists prevent in vivo remodeling of human artery induced by alloreactive T cells. 2011 Circulation pmid:21690493
Takeda K et al. Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells. 2000 Circulation pmid:11023940
Yamamoto K et al. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. 2001 Circulation pmid:11581147
Walusinski O How yawning switches the default-mode network to the attentional network by activating the cerebrospinal fluid flow. 2014 Clin Anat pmid:23813685
Holgate ST et al. The release and role of inflammatory mediators in asthma. 1985 Clin Immunol Rev pmid:2417772
Inoué S Multifactorial humoral regulation of sleep. 1986 Clin Neuropharmacol pmid:3471328
Mickleborough TD et al. Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells. 2009 Clin Nutr pmid:19054597
Damrongsri D et al. Effects of Delta12-prostaglandin J2 on bone regeneration and growth factor expression in rats. 2006 Clin Oral Implants Res pmid:16441784
Bedwani JR et al. Effects of prostaglandins E2, I2 and D2 on pig nasal vasculature. 1983 Clin Otolaryngol Allied Sci pmid:6357570
Philips JB and Lyrene RK Prostaglandins, related compounds, and the perinatal pulmonary circulation. 1984 Clin Perinatol pmid:6386270
Beasley R et al. Comparative vascular effects of histamine, prostaglandin (PG) D2 and its metabolite 9 alpha,11 beta-PGF2 in human skin. 1988 Clin. Allergy pmid:3242978
Lebel B et al. Spontaneous and non-specific release of histamine and PGD2 by bronchoalveolar lavage cells from asthmatic and normal subjects: effect of nedocromil sodium. 1988 Clin. Allergy pmid:2468432